North Star Investment Management Corp. Nektar Therapeutics Transaction History

North Star Investment Management Corp.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Oct 03, 2019	BUY	$16.91 - $36.27 $2,113 - $4,533	125 New	125 $2,000
Q2 2019 Jul 15, 2019	SELL	$31.0 - $36.3 $2,325 - $2,722	-75 Closed	0 $0
Q4 2018 Jan 07, 2019	BUY	$30.43 - $56.65 $760 - $1,416	25 Added 50.0%	75 $2,000
Q3 2018 Oct 11, 2018	BUY	$46.46 - $68.49 $2,323 - $3,424	50 New	50 $3,000

147

139M

32.6K

14.1K

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $201M
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

Get notified when there are updates to the investment portfolio of North Star Investment Management Corp., based on Form 13F filings with the SEC.

Stay updated on North Star Investment Management Corp. with notifications on news.